E. Pindinelli, T. Pilati, L. Troisi
FULL PAPER
(1,2-Dipyridin-2-ylvinyl)thiazol-2-ylamine (14a): Yield: 115 mg
(41%), oil. 1H NMR (400.13 MHz, CDCl3): δ = 6.17 (s, 1 H), 6.58
(d, J = 3.6 Hz, 1 H), 7.08 (dd, J = 6.0, 7.4 Hz, 1 H), 7.18–7.23 (m,
2 H), 7.30 (dd, J = 6.0, 7.4 Hz, 1 H), 7.58 (d, J = 7.9 Hz, 1 H),
7.64 (td, J = 1.8, 7.9 Hz, 1 H), 7.69 (td, J = 1.9, 7.9 Hz, 1 H), 8.60
(d, J = 4.5 Hz, 1 H), 8.70 (d, J = 4.6 Hz, 1 H), 11.18 (br. s, ex-
changes with D2O, 1 H) ppm. 13C NMR (100.62 MHz, CDCl3): δ
= 108.7, 111.1, 120.3, 123.4, 123.9, 124.2, 136.3, 136.5, 138.8, 144.3,
7.06–7.13 (m, 2 H), 7.23 (d, J = 5.5 Hz, 2 H), 7.39 (t, J = 7.5 Hz,
1 H), 7.47 (t, J = 7.5 Hz, 1 H), 7.87 (d, J = 7.9 Hz, 1 H), 7.90 (d,
J = 8.1 Hz, 1 H), 8.21–8.28 (m, 2 H), 8.59 (d, J = 5.5 Hz, 2 H)
ppm. 13C NMR (100.62 MHz, CDCl3): δ = 47.2, 48.3, 121.6, 121.9,
123.2, 123.4, 125.6, 126.5, 127.8, 134.8, 142.7, 143.1, 143.9, 144.5,
150.0, 153.1, 164.4 ppm. IR (CHCl ): ν = 3064, 3037, 2987, 1602,
˜
3
1480, 1426, 1245 cm–1. GC–MS (70 eV): m/z (%) = 330 (37) [M]+,
252 (100), 148 (11), 78 (10). HRMS (ESI): calcd. for C19H15N4S
147.8, 149.7, 154.2, 156.9, 165.2 ppm. IR (CHCl ): ν = 3297 (br.), 331.10195 [M + H]+; found 331.10191.
˜
3
3061, 2958, 1632, 1590, 1521, 1469, 1373, 1159 cm–1. GC–MS
(R*,R*)-17: Yield: 56 mg (17%), oil. 1H NMR (400.13 MHz,
(70 eV): m/z (%) = 280 (35) [M]+, 247 (90), 202 (100), 78 (38) cm–1.
HRMS (ESI): calcd. for C15H13N4S: 281.08629, [M + H]+; found
281.08627
CDCl3): δ = 3.90 (d, J = 6.5 Hz, 1 H), 4.19 (d, J = 6.5 Hz, 1 H),
7.25–7.29 (m, 1 H), 7.33 (t, J = 8.0 Hz, 1 H), 7.41–7.47 (m, 4 H),
7.66 (d, J = 7.9 Hz, 1 H), 7.93 (d, J = 8.1 Hz, 1 H), 8.40 (dd, J =
1.1, 4.6 Hz, 1 H), 8.50–8.52 (m, 3 H) ppm. 13C NMR (100.62 MHz,
CDCl3): δ = 46.9, 48.2, 121.5, 122.7, 122.8, 123.7, 125.2, 126.1,
127.0, 134.6, 142.1, 142.4, 145.4, 147.8, 149.6, 153.3, 166.1 ppm.
[1,2-Bis(4-methylthiazol-2-yl)vinyl]thiazol-2-ylamine (15a): Yield:
1
211 mg (66%), oil. H NMR (400.13 MHz, CDCl3): δ = 2.49 (s, 3
H), 2.50 (s, 3 H), 6.46 (s, 1 H), 6.70 (d, J = 3.5 Hz, 1 H), 6.78 (s,
1 H), 7.00 (s, 1 H), 7.28 (d, J = 3.5 Hz, 1 H), 11.21 (br. s, exchanges
with D2O, 1 H) ppm. 13C NMR (100.62 MHz, CDCl3): δ = 17.2,
103.47, 103.50, 112.3, 116.1, 136.7, 139.0, 153.3, 153.8, 162.2,
IR (CHCl ): ν = 3065, 3039, 2966, 1605, 1585, 1479, 1427,
˜
3
1241 cm–1.GC–MS (70 eV): m/z (%) = 330 (30) [M]+, 252 (100),
148 (12), 78 (9). HRMS (ESI): calcd. for C19H15N4S 331.10195 [M
+ H]+; found 331.10189.
163.9, 164.5 ppm. IR (CHCl ): ν = 3225 (br.), 3116, 2980, 2927,
˜
3
2863, 1617, 1522, 1443, 1263, 1156, 1112 cm–1. GC–MS (70 eV):
m/z (%) = 320 (94) [M]+, 319 (47), 287 (100), 222 (96). HRMS
(ESI): calcd. for C13H13N4S 321.03049 [M + H]+; found 321.03048.
(2-Benzothiazol-2-yl-1-pyridin-4-yl-vinyl)pyridin-3-yl-amine
17a:
Yield: 1.0%. GC–MS (70 eV): m/z (%) = 330 (60) [M]+, 329 (55),
252 (100), 196 (50), 78 (40).
2-(1-Pyridin-3-yl-3-pyridin-4-ylaziridin-2-yl)pyridine (16)
2-(3-Pyridin-2-yl-1-pyridin-3-ylaziridin-2-yl)benzothiazole [(R*,S*)-
18]: Yield: 212 mg (64%), oil. 1H NMR (400.13 MHz, CDCl3): δ
= 4.16 (d, J = 2.6 Hz, 1 H), 4.70 (d, J = 2.6 Hz, 1 H), 7.03–7.06
(m, 1 H), 7.13–7.16 (m, 2 H), 7.38 (t, J = 7.4 Hz, 1 H), 7.48 (t, J
= 8.5 Hz, 2 H), 7.67 (td, J = 1.5, 7.6 Hz, 1 H), 7.86 (d, J = 8.0 Hz,
1 H), 7.97 (d, J = 8.0 Hz, 1 H), 8.12–8.16 (m, 2 H), 8.40 (d, J =
4.5 Hz, 1 H) ppm. 13C NMR (100.62 MHz, CDCl3): δ = 45.4, 51.0,
121.7, 122.9, 123.0, 123.1, 123.9, 125.3, 126.3, 127.7, 134.8, 136.5,
(R*,S*)-16: Yield: 100 mg (36.4%), oil. 1H NMR (400.13 MHz,
CDCl3): δ = 3.81 (d, J = 2.6 Hz, 1 H), 4.18 (d, J = 2.6 Hz, 1 H),
6.99–7.05 (m, 2 H), 7.13–7.16 (m, 1 H), 7.29 (d, J = 5.9 Hz, 2 H),
7.43 (d, J = 7.8 Hz, 1 H), 7.67 (td, J = 1.7, 7.8 Hz, 1 H), 8.03–8.04
(m, 1 H), 8.14 (dd, J = 1.7, 4.4 Hz, 1 H), 8.37 (d, J = 4.4 Hz, 1 H),
8.58 (d, J = 5.9 Hz, 2 H) ppm. 13C NMR (100.62 MHz, CDCl3): δ
= 45.9, 50.7, 121.9, 122.7, 123.1, 124.1, 127.6, 136.5, 142.7, 143.4,
144.2, 145.9, 149.2, 149.8, 152.8 ppm. IR (CHCl ): ν = 3079, 3036,
˜
3
142.9, 143.7, 143.8, 149.4, 152.4, 153.5, 167.9 ppm. IR (CHCl ): ν
˜
3
2967, 2929, 2856, 1602, 1590, 1479, 1424 cm–1. GC–MS (70 eV):
m/z (%) = 274 (11) [M]+, 273 (7), 196 (100), 181 (21), 169 (16), 78
(35). HRMS (ESI): calcd. for C17H15N4 275.12985 [M + H]+; found
275.12981.
= 3063, 2988, 2857, 1591, 1480, 1425, 1241 cm–1. GC–MS (70 eV):
m/z (%) = 330 (80) [M]+, 329 (90), 297 (17), 281 (15), 252 (52), 196
(100), 182 (45). HRMS (ESI): calcd. for C19H15N4S 331.10195 [M
+ H]+; found 331.10190.
(R*,R*)-16: Yield: 55 mg (20%), oil. 1H NMR (400.13 MHz,
CDCl3): δ = 3.75 (d, J = 6.7 Hz, 1 H), 3.94 (d, J = 6.7 Hz, 1 H),
7.03 (t, J = 7 Hz, 1 H), 7.17–7.24 (m, 4 H), 7.35 (d, J = 7.5 Hz, 1
H), 7.47 (t, J = 7.5 Hz, 1 H), 8.29 (d, J = 4.2 Hz, 1 H), 8.36–8.42
(m, 4 H) ppm. 13C NMR (100.62 MHz, CDCl3): δ = 47.6, 49.7,
121.9, 122.6, 122.7, 123.7, 127.1, 136.2, 142.5, 143.8, 144.9, 149.0,
(2-Benzothiazol-2-yl-1-pyridin-2-yl-vinyl)pyridin-3-yl-amine (18a):
Yield: 45 mg (14%), oil. H NMR (400.13 MHz, CDCl3): δ = 6.31
1
(s, 1 H), 6.96–6.98 (m, 1 H), 7.04–7.07 (m, 1 H), 7.26–7.34 (m, 2
H), 7.40 (d, J = 7.8 Hz, 1 H), 7.46 (td, J = 1.1, 7.4 Hz, 1 H), 7.64
(td, J = 1.7, 7.8 Hz, 1 H), 7.82 (d, J = 8.0 Hz, 1 H), 7.94 (d, J =
8.2 Hz, 1 H), 8.17 (dd, J = 1.1, 4.6 Hz, 1 H), 8.22 (d, J = 2.6 Hz,
1 H), 8.68 (dd, J = 1.1, 4.8 Hz, 1 H) 11.18 (br. s, exchanges with
D2O, 1 H) ppm. 13C NMR (100.62 MHz, CDCl3): δ = 100.3, 121.3,
121.7, 123.2, 123.7, 123.8, 124.3, 126.2, 127.7, 133.4, 136.6, 138.3,
149.38, 149.45, 154.1 ppm. IR (CHCl ): ν = 3061, 3038, 2972, 1601,
˜
3
1587, 1479, 1405, 1275 cm–1. GC–MS (70 eV): m/z (%) = 274 (21)
[M]+, 196 (100), 181 (15), 169 (12), 92 (17), 78 (15). HRMS (ESI):
calcd. for C17H15N4 275.12985 [M + H]+; found 275.12980.
143.0, 143.3, 147.2, 150.8, 153.4, 153.7, 166.3 ppm. IR (CHCl ): ν
˜
3
= 3249 (br.), 3064, 2964, 1621, 1584, 1470, 1435, 1292, 1121 cm–1.
GC–MS (70 eV): m/z (%) = 330 (43) [M]+, 329 (58), 281 (9), 252
(100), 238 (33), 207 (16) cm–1. HRMS (ESI): calcd. for C19H15N4S
331.10195 [M + H]+; found 331.10197.
Pyridin-3-yl-(2-pyridin-2-yl-1-pyridin-4-yl-vinyl)amine (16a): Yield:
1
23 mg (8.5%), oil. H NMR (400.13 MHz, CDCl3): δ = 5.81 (s, 1
H), 6.80 (d, J = 8.2 Hz, 1 H), 6.98 (dd, J = 4.7, 8.1 Hz, 1 H), 7.06
(dd, J = 5.2, 6.6 Hz, 1 H), 7.18 (d, J = 8.1 Hz, 1 H), 7.37 (d, J =
5.9 Hz, 2 H), 7.64 (td, J = 1.7, 7.9 Hz, 1 H), 8.10 (d, J = 3.6 Hz, 1
H), 8.20 (d, J = 2.6 Hz, 1 H), 8.54 (d, J = 4.2 Hz, 1 H), 8.58 (d, J
= 5.9 Hz, 2 H), 11.72 (br. s, exchanges with D2O, 1 H) ppm. 13C
NMR (100.62 MHz, CDCl3): δ = 107.3, 119.9, 122.2, 123.1, 123.8,
127.1, 136.4, 138.5, 142.3, 142.5, 144.5, 145.2, 147.6, 150.1,
(1-Benzothiazol-2-yl-2-pyridin-2-yl-vinyl)pyridin-3-yl-amine (18b):
1
Yield: 45 mg (14%), oil. H NMR (400.13 MHz, CDCl3): δ = 6.59
(s, 1 H), 7.02–7.12 (m, 3 H), 7.30 (d, J = 8.0 Hz, 1 H), 7.39 (t, J =
7.2 Hz, 1 H), 7.50 (t, J = 8.0 Hz, 1 H), 7.67 (td, J = 1.8, 7.8 Hz, 1
H), 7.81 (d, J = 8.0 Hz, 1 H), 8.06 (d, J = 8.0 Hz, 1 H), 8.13 (dd,
J = 1.4, 4.0 Hz, 1 H), 8.31 (d, J = 2.6 Hz, 1 H), 8.56 (d, J = 4.6 Hz,
1 H), 11.37 (br. s, exchanges with D2O, 1 H) ppm. 13C NMR
(100.62 MHz, CDCl3): δ = 110.4, 120.8, 121.7, 123.3, 123.6, 124.7,
125.6, 126.4, 127.0, 135.6, 136.6, 139.3, 139.4, 142.5, 142.8, 147.9,
157.3 ppm. IR (CHCl ): ν = 3250 (br.), 3060, 2965, 2929, 1626,
˜
3
1594, 1471, 1414, 1262 cm–1. GC–MS (70 eV): m/z (%) = 274 (19)
[M]+, 273 (30), 196 (100), 182 (15), 169 (22), 78 (43). HRMS (ESI):
calcd. for C17H15N4 275.12985 [M + H]+; found 275.12987.
2-(3-Pyridin-4-yl-1-pyridin-3-ylaziridin-2-yl)benzothiazole (17)
(R*,S*)-17: Yield: 155 mg (47%), oil. 1H NMR (400.13 MHz,
CDCl3): δ = 4.10 (d, J = 2.2 Hz, 1 H), 4.18 (d, J = 2.2 Hz, 1 H),
153.2, 156.6, 165.8 ppm. IR (CHCl ): ν = 3243 (br.), 3063, 2990,
˜
3
1622, 1588, 1499, 1470, 1434, 1257 cm–1. GC–MS (70 eV): m/z (%)
= 330 (45) [M]+, 329 (57), 281 (30), 252 (100), 238 (38), 207
5930
www.eurjoc.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2007, 5926–5933